Company Filing History:
Years Active: 2010
Title: Ofra Levi-Hacham: Innovator in Ubiquitin Ligase Inhibitors
Introduction
Ofra Levi-Hacham is a notable inventor based in Petah Tiqwa, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit ubiquitin ligase activity. Her work has implications for various medical applications, including antiviral and anticancer treatments.
Latest Patents
Ofra holds a patent for "Ubiquitin ligase inhibitors and methods related thereto." This patent discloses compounds that inhibit ubiquitin ligase activity, which is crucial for regulating protein degradation in cells. The application further details antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders. She has 1 patent to her name.
Career Highlights
Throughout her career, Ofra has worked with several companies, including Proteologies, Ltd. and Proteologics, Inc. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the biotechnology sector.
Collaborations
Ofra has collaborated with notable colleagues, including Iris Alroy and Shmuel Tuvia. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Ofra Levi-Hacham is a pioneering inventor whose work on ubiquitin ligase inhibitors has the potential to transform treatments for various diseases. Her contributions to biotechnology continue to inspire advancements in medical research.